885 related articles for article (PubMed ID: 28134564)
21. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.
Bally L; Thabit H; Tauschmann M; Allen JM; Hartnell S; Wilinska ME; Exall J; Huegel V; Sibayan J; Borgman S; Cheng P; Blackburn M; Lawton J; Elleri D; Leelarathna L; Acerini CL; Campbell F; Shah VN; Criego A; Evans ML; Dunger DB; Kollman C; Bergenstal RM; Hovorka R
BMJ Open; 2017 Jul; 7(7):e016738. PubMed ID: 28710224
[TBL] [Abstract][Full Text] [Related]
22. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Brown SA; Kovatchev BP; Raghinaru D; Lum JW; Buckingham BA; Kudva YC; Laffel LM; Levy CJ; Pinsker JE; Wadwa RP; Dassau E; Doyle FJ; Anderson SM; Church MM; Dadlani V; Ekhlaspour L; Forlenza GP; Isganaitis E; Lam DW; Kollman C; Beck RW;
N Engl J Med; 2019 Oct; 381(18):1707-1717. PubMed ID: 31618560
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed
Cordero TL; Garg SK; Brazg R; Bailey TS; Shin J; Lee SW; Kaufman FR
Diabetes Technol Ther; 2017 Dec; 19(12):749-752. PubMed ID: 29148821
[TBL] [Abstract][Full Text] [Related]
24. Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
Wadwa RP; Reed ZW; Buckingham BA; DeBoer MD; Ekhlaspour L; Forlenza GP; Schoelwer M; Lum J; Kollman C; Beck RW; Breton MD;
N Engl J Med; 2023 Mar; 388(11):991-1001. PubMed ID: 36920756
[TBL] [Abstract][Full Text] [Related]
25. Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.
Garg SK; Grunberger G; Weinstock R; Lawson ML; Hirsch IB; DiMeglio LA; Pop-Busui R; Philis-Tsimikas A; Kipnes M; Liljenquist DR; Brazg RL; Kudva YC; Buckingham BA; McGill JB; Carlson AL; Criego AB; Christiansen MP; Kaiserman KB; Griffin KJ; Forlenza GP; Bode BW; Slover RH; Keiter A; Ling C; Marinos B; Cordero TL; Shin J; Lee SW; Rhinehart AS; Vigersky RA;
Diabetes Technol Ther; 2023 Jan; 25(1):1-12. PubMed ID: 36472543
[No Abstract] [Full Text] [Related]
26. Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study.
Lepore G; Scaranna C; Corsi A; Dodesini AR; Trevisan R
Diabetes Technol Ther; 2020 Apr; 22(4):321-325. PubMed ID: 31617752
[TBL] [Abstract][Full Text] [Related]
27. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
Breton MD; Kanapka LG; Beck RW; Ekhlaspour L; Forlenza GP; Cengiz E; Schoelwer M; Ruedy KJ; Jost E; Carria L; Emory E; Hsu LJ; Oliveri M; Kollman CC; Dokken BB; Weinzimer SA; DeBoer MD; Buckingham BA; Cherñavvsky D; Wadwa RP;
N Engl J Med; 2020 Aug; 383(9):836-845. PubMed ID: 32846062
[TBL] [Abstract][Full Text] [Related]
28. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
Ware J; Allen JM; Boughton CK; Wilinska ME; Hartnell S; Thankamony A; de Beaufort C; Schierloh U; Fröhlich-Reiterer E; Mader JK; Kapellen TM; Rami-Merhar B; Tauschmann M; Nagl K; Hofer SE; Campbell FM; Yong J; Hood KK; Lawton J; Roze S; Sibayan J; Bocchino LE; Kollman C; Hovorka R;
N Engl J Med; 2022 Jan; 386(3):209-219. PubMed ID: 35045227
[TBL] [Abstract][Full Text] [Related]
29. Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.
Lee TTM; Collett C; Bergford S; Hartnell S; Scott EM; Lindsay RS; Hunt KF; McCance DR; Barnard-Kelly K; Rankin D; Lawton J; Reynolds RM; Flanagan E; Hammond M; Shepstone L; Wilinska ME; Sibayan J; Kollman C; Beck R; Hovorka R; Murphy HR;
N Engl J Med; 2023 Oct; 389(17):1566-1578. PubMed ID: 37796241
[TBL] [Abstract][Full Text] [Related]
30. Home Use of an Artificial Beta Cell in Type 1 Diabetes.
Thabit H; Tauschmann M; Allen JM; Leelarathna L; Hartnell S; Wilinska ME; Acerini CL; Dellweg S; Benesch C; Heinemann L; Mader JK; Holzer M; Kojzar H; Exall J; Yong J; Pichierri J; Barnard KD; Kollman C; Cheng P; Hindmarsh PC; Campbell FM; Arnolds S; Pieber TR; Evans ML; Dunger DB; Hovorka R
N Engl J Med; 2015 Nov; 373(22):2129-2140. PubMed ID: 26379095
[TBL] [Abstract][Full Text] [Related]
31. Performance of Medtronic Hybrid Closed-Loop Iterations: Results from a Randomized Trial in Adolescents with Type 1 Diabetes.
de Bock M; Dart J; Hancock M; Smith G; Davis EA; Jones TW
Diabetes Technol Ther; 2018 Oct; 20(10):693-697. PubMed ID: 30204486
[TBL] [Abstract][Full Text] [Related]
32. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of advanced hybrid closed loop systems in children with type 1 diabetes younger than 6 years.
Rapini N; Martino M; Arnaldi C; Deodati A; Anagnostopoulou L; Amodeo ME; Ciampalini P; Pampanini V; Lorubbio A; Tosini D; Cianfarani S; Schiaffini R
Front Endocrinol (Lausanne); 2024; 15():1382920. PubMed ID: 38836230
[TBL] [Abstract][Full Text] [Related]
34. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.
Petrovski G; Al Khalaf F; Campbell J; Umer F; Almajaly D; Hamdan M; Hussain K
Acta Diabetol; 2021 Feb; 58(2):207-213. PubMed ID: 33044604
[TBL] [Abstract][Full Text] [Related]
35. One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System.
Lal RA; Basina M; Maahs DM; Hood K; Buckingham B; Wilson DM
Diabetes Care; 2019 Dec; 42(12):2190-2196. PubMed ID: 31548247
[TBL] [Abstract][Full Text] [Related]
36. Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.
Tauschmann M; Allen JM; Wilinska ME; Thabit H; Stewart Z; Cheng P; Kollman C; Acerini CL; Dunger DB; Hovorka R
Diabetes Care; 2016 Jul; 39(7):1168-74. PubMed ID: 26740634
[TBL] [Abstract][Full Text] [Related]
37. Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial.
Ware J; Boughton CK; Allen JM; Wilinska ME; Tauschmann M; Denvir L; Thankamony A; Campbell FM; Wadwa RP; Buckingham BA; Davis N; DiMeglio LA; Mauras N; Besser REJ; Ghatak A; Weinzimer SA; Hood KK; Fox DS; Kanapka L; Kollman C; Sibayan J; Beck RW; Hovorka R;
Lancet Digit Health; 2022 Apr; 4(4):e245-e255. PubMed ID: 35272971
[TBL] [Abstract][Full Text] [Related]
38. Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial.
Forlenza GP; Ekhlaspour L; DiMeglio LA; Fox LA; Rodriguez H; Shulman DI; Kaiserman KB; Liljenquist DR; Shin J; Lee SW; Buckingham BA
Pediatr Diabetes; 2022 May; 23(3):324-329. PubMed ID: 35001477
[TBL] [Abstract][Full Text] [Related]
39. Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial.
Kim JY; Jin SM; Kang ES; Kwak SH; Yang Y; Yoo JH; Bae JH; Moon JS; Jung CH; Bae JC; Suh S; Moon SJ; Song SO; Chon S; Kim JH
Diabetologia; 2024 Jul; 67(7):1235-1244. PubMed ID: 38634887
[TBL] [Abstract][Full Text] [Related]
40. Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod
DeSalvo DJ; Bode BW; Forlenza GP; Laffel LM; Buckingham BA; Criego AB; Schoelwer M; MacLeish SA; Sherr JL; Hansen DW; Ly TT
Diabetes Technol Ther; 2024 Jun; 26(6):383-393. PubMed ID: 38277156
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]